Sino Biopharmaceutical Limited (1177.HK)
HKD 3.72
(-0.53%)
HKD 3.72
(-0.53%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 12.58 Billion CNY | -10.03% |
| 2022 | 13.98 Billion CNY | 15.39% |
| 2021 | 12.11 Billion CNY | -14.72% |
| 2020 | 14.2 Billion CNY | 64.93% |
| 2019 | 8.61 Billion CNY | 152.47% |
| 2018 | 3.41 Billion CNY | 15.64% |
| 2017 | 2.95 Billion CNY | -3.14% |
| 2016 | 3.04 Billion CNY | 110.8% |
| 2015 | 1.44 Billion CNY | 4.86% |
| 2014 | 1.37 Billion CNY | 2278.87% |
| 2013 | 57.94 Million CNY | 75.31% |
| 2012 | 33.05 Million CNY | -52.03% |
| 2011 | 68.9 Million CNY | -47.94% |
| 2010 | 132.34 Million CNY | 13132.37% |
| 2009 | 1 Million CNY | -98.89% |
| 2008 | 90 Million CNY | 64.64% |
| 2007 | 54.66 Million CNY | 0.0% |
| 2006 | - CNY | 0.0% |
| 2005 | - CNY | -100.0% |
| 2004 | 45.7 Million CNY | -45.04% |
| 2003 | 83.16 Million CNY | 0.0% |
| 2002 | - CNY | 0.0% |
| 2001 | - CNY | -100.0% |
| 2000 | 25.53 Million CNY | -54.34% |
| 1999 | 55.92 Million CNY | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 9.51 Billion CNY | 1.74% |
| 2024 Q1 | 9.51 Billion CNY | -24.4% |
| 2023 Q4 | 12.58 Billion CNY | -0.51% |
| 2023 FY | 12.58 Billion CNY | -10.03% |
| 2023 Q3 | 12.64 Billion CNY | 9.44% |
| 2023 Q2 | 11.55 Billion CNY | 0.33% |
| 2023 Q1 | 11.51 Billion CNY | -17.63% |
| 2022 Q2 | 12.01 Billion CNY | 0.41% |
| 2022 Q4 | 13.98 Billion CNY | -0.54% |
| 2022 FY | 13.98 Billion CNY | 15.39% |
| 2022 Q3 | 14.05 Billion CNY | 16.98% |
| 2022 Q1 | 11.96 Billion CNY | -1.24% |
| 2021 FY | 12.11 Billion CNY | -14.72% |
| 2021 Q1 | 13.79 Billion CNY | -2.95% |
| 2021 Q2 | 13.65 Billion CNY | -0.99% |
| 2021 Q3 | 12.18 Billion CNY | -10.72% |
| 2021 Q4 | 12.11 Billion CNY | -0.59% |
| 2020 Q1 | 13.99 Billion CNY | 62.42% |
| 2020 Q2 | 14.76 Billion CNY | 5.51% |
| 2020 Q3 | 14.28 Billion CNY | -3.28% |
| 2020 Q4 | 14.2 Billion CNY | -0.49% |
| 2020 FY | 14.2 Billion CNY | 64.93% |
| 2019 Q2 | 3.26 Billion CNY | -2.59% |
| 2019 Q1 | 3.35 Billion CNY | -1.72% |
| 2019 Q4 | 8.61 Billion CNY | 156.67% |
| 2019 FY | 8.61 Billion CNY | 152.47% |
| 2019 Q3 | 3.35 Billion CNY | 2.74% |
| 2018 FY | 3.41 Billion CNY | 15.64% |
| 2018 Q2 | 3.29 Billion CNY | 7.14% |
| 2018 Q1 | 3.07 Billion CNY | 4.16% |
| 2018 Q4 | 3.41 Billion CNY | -4.1% |
| 2018 Q3 | 3.55 Billion CNY | 8.05% |
| 2017 Q3 | 3 Billion CNY | 14.12% |
| 2017 Q4 | 2.95 Billion CNY | -1.72% |
| 2017 Q2 | 2.63 Billion CNY | -8.05% |
| 2017 Q1 | 2.86 Billion CNY | -6.08% |
| 2017 FY | 2.95 Billion CNY | -3.14% |
| 2016 FY | 3.04 Billion CNY | 110.8% |
| 2016 Q3 | 2.2 Billion CNY | 49.38% |
| 2016 Q4 | 3.04 Billion CNY | 37.89% |
| 2016 Q1 | 1.44 Billion CNY | 0.1% |
| 2016 Q2 | 1.47 Billion CNY | 2.24% |
| 2015 FY | 1.44 Billion CNY | 4.86% |
| 2015 Q4 | 1.44 Billion CNY | 1.77% |
| 2015 Q2 | 1.47 Billion CNY | 0.02% |
| 2015 Q1 | 1.47 Billion CNY | 7.14% |
| 2015 Q3 | 1.42 Billion CNY | -3.85% |
| 2014 Q4 | 1.37 Billion CNY | 28.05% |
| 2014 Q2 | 1.09 Billion CNY | 312.76% |
| 2014 Q3 | 1.07 Billion CNY | -1.96% |
| 2014 FY | 1.37 Billion CNY | 2278.87% |
| 2014 Q1 | 266 Million CNY | 359.07% |
| 2013 Q4 | 57.94 Million CNY | 15.92% |
| 2013 FY | 57.94 Million CNY | 75.31% |
| 2013 Q3 | 49.98 Million CNY | 38.26% |
| 2013 Q2 | 36.15 Million CNY | 0.33% |
| 2013 Q1 | 36.03 Million CNY | 9.03% |
| 2012 Q3 | 194.49 Million CNY | 15.93% |
| 2012 Q4 | 33.05 Million CNY | -83.01% |
| 2012 FY | 33.05 Million CNY | -52.03% |
| 2012 Q2 | 167.77 Million CNY | 0.0% |
| 2011 Q4 | 68.9 Million CNY | -57.56% |
| 2011 Q1 | 198.43 Million CNY | 0.0% |
| 2011 FY | 68.9 Million CNY | -47.94% |
| 2011 Q2 | 152.11 Million CNY | -23.34% |
| 2011 Q3 | 162.35 Million CNY | 6.73% |
| 2010 Q2 | 71.89 Million CNY | 0.0% |
| 2010 FY | 132.34 Million CNY | 13132.37% |
| 2009 Q4 | 1 Million CNY | 0.0% |
| 2009 FY | 1 Million CNY | -98.89% |
| 2008 FY | 90 Million CNY | 64.64% |
| 2007 FY | 54.66 Million CNY | 0.0% |
| 2006 FY | - CNY | 0.0% |
| 2005 FY | - CNY | -100.0% |
| 2004 FY | 45.7 Million CNY | -45.04% |
| 2003 FY | 83.16 Million CNY | 0.0% |
| 2002 FY | - CNY | 0.0% |
| 2001 FY | - CNY | -100.0% |
| 2000 FY | 25.53 Million CNY | -54.34% |
| 1999 FY | 55.92 Million CNY | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Uni-Bio Science Group Limited | 52.86 Million HKD | -23696.024% |
| CK Life Sciences Int'l., (Holdings) Inc. | 5.93 Billion HKD | -112.106% |